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Abstract
International experience and evidence-based practices have shown that reduction in variability through use of
protocolized perioperative care improves surgical outcomes and reduces costs to patients and healthcare systems.
In this series of Expert Opinions, we provide consensus recommendations for the various components of
perioperative care to aid with the development of enhanced recovery after surgery protocols.
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Parameter definition
Early ambulation, early feeding, and early return of
bowel function are linked with quicker recovery, earlier
discharge, and improved satisfaction. Postoperative nau-
sea and vomiting (PONV) is a common complication
following abdominal surgical procedures with patient
(young age, female sex, history of motion sickness),
anesthetic (use of opioids and volatile anesthetics), and
surgical (length of case, use of insufflation, manipulation
of the bowel) factors contributing to its incidence and
severity. Nausea and vomiting should be viewed as exist-
ing on a continuum, and sequelae and patient discom-
fort vary based on patient experience, surgical
procedure, and recovery profile. Guidelines for its avoid-
ance and treatment are based on evidence-based litera-
ture, expert opinion, and professional association
recommendations [ASPAN’S evidence-based clinical
practice opinion for the prevention and/or management
of PONV/PDNV. J Perianesth Nurs 2006 [Gan et al.
2007] Gan et al. 2014. Gan et al. 2003.
Discussion
Prophylaxis of PONV is based on a number of risk fac-
tors [Apfel et al. 1999, presented here as modifiable and
non-modifiable:
1. Modifiable risk factors
a. Use of volatile anesthetics
b. Intraoperative use of opioids
c. Surgical/anesthetic time
d. Smoking (tobacco use decreases PONV risk)
2. Non-modifiable risk factors Apfel et al. 2012a
a. Female sex
b. Young age (<50)
c. History of PONV
d. Surgical location (abdominal/pelvic, ENT, breast)
e. Surgical technique (laparoscopic)
The number of medications/techniques used for
prophylaxis is dictated by the numbers of risk factors
present. Patients with ≤1 risk should be considered at
low risk, and those with ≥3 should be considered at high
risk [Apfel et al. 2012b]. Prophylaxis and treatment
should rely on modification of anesthetic technique, if
possible, and the use of medications that work at a var-
iety of receptor sites allowing for full multimodal benefit.
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Non-pharmacologic techniques include ensuring appro-
priate analgesia and hydration, acupuncture/acupressure,
and aromatherapy. Pharmacologic techniques include
medications that work at different receptor sites:
1. Serotonin antagonists (e.g., ondansetron)
2. Dopamine antagonists (e.g., droperidol,
metoclopramide)
3. Anticholinergics (e.g., scopolamine)
4. Antihistamines (e.g., diphenhydramine)
5. Steroids (e.g., dexamethasone)
6. Others (e.g., trimethobenzamide)
Conclusion
ASER Expert Opinion
All patients should receive PONV prophylaxis during
the perioperative period. The numbers of medications
used for treatment and prophylaxis should be deter-
mined by the number of modifiable and non-modifiable
risk factors. Medications used should represent different
mechanisms of action in an attempt to achieve multi-
modal benefit Tramèr 2001.
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